In 2025, 2,049 medical device products are due to launch globally, according to GlobalData’s Pipeline Products database. Further intelligence from GlobalData reveals that the top three markets for medical devices in the pipeline are in vitro diagnostics, digital health, and cardiovascular devices.
“Some of the biggest themes we’re going to see in 2025 are AI, robotics, 3D printing, and precision medicine,” notes Alexandra Murdoch, senior analyst at GlobalData.
With potential regulatory change in the US also causing uncertainty, agility will be essential for medical device companies to stay ahead of the curve in 2025.
Regulatory changes in the US?
Medical device manufacturers will be especially interested in how the US market will develop in 2025 as the new administration enters office. There could be changes to regulations that will need to be factored into development times.
Adherence to global standards and more simplified regulations could reduce the cost of medical devices throughout their lifecycle and improve pricing, as well as profits.
For medical devices to reach the US market more quickly, having expert partners on hand will be more critical than ever to ensure that devices meet the highest standards in shorter timelines. The right suppliers will be able to provide stability and assurance amid the uncertainty that may arise after possible regulatory changes.
AI will continue to be impactful in medical devices
The issue of regulation is especially important as use cases of artificial intelligence (AI) increase. The rise of AI-powered algorithms goes hand-in-hand with the trend towards personalised medicine, with AI technology able to provide better assessments of patient health. This will continue to impact the medical devices world in 2025, especially as precision medicine and AI enhance cardiovascular disease testing.
Demands for pacemakers and other cardiovascular devices may well increase in line with these changes. With devices collecting more data, they will also require specialist coatings to ensure that they function as intended once fitted in patients.
“Precision medicine is growing in popularity because of advances in technology and medicine like AI and genomics. It allows for more tailored treatments as opposed to a ‘one size fits all’ method, so the quality of care and patient experiences are generally improved,” notes Murdoch.
“AI has obviously been massive in the last couple of years in the medical industry. It has and will continue to be used in diagnostics and imaging,” she adds. “It can automate administrative tasks, assist clinicians in making more accurate diagnoses by analysing patient data and test results, and more.”
Choosing a flexible partner for medical device coatings
With the outlook for 2025 somewhat cautious on account of regulatory uncertainty, expert suppliers are needed, who can be agile as the market evolves while also providing high-quality products. Relying on fewer suppliers presents a considerable advantage in reducing production delays and ensuring devices reach patients faster.
Based in Minnesota, Formacoat is a leading provider of medical device coatings. The company offers an extensive range of coatings from trusted vendors, but its innovative R&D department is happy to create custom coatings tailored to precise performance requirements.
“We are very much specialists in the application of coatings to get our customers to market,” says Todd Paulsen, vice-president of Formacoat. “We have so many different coatings to choose from and can pivot quickly.”
This inbuilt flexibility, alongside its years of expertise, makes Formacoat an ideal partner for possible changes in the year ahead.
To learn more, download the document below.
